Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice.
Acetaminophen (AAP) overdose causes formation of peroxynitrite in centrilobular hepatocytes. Treatment with glutathione (GSH) after AAP accelerated recovery of mitochondrial GSH levels, which scavenged peroxynitrite and protected against liver injury at 6 h. The objective of this investigation was to evaluate whether GSH treatment has a long-term protective effect against AAP-induced injury and whether it promotes liver regeneration. AAP (300 mg/kg) induced severe centrilobular necrosis and increased plasma alanine aminotransferase (ALT) activities (24 h: 3680 +/- 320 U/liter) in fasted C3Heb/FeJ mice. Only 53% of the animals survived for 24 h. Hepatic glutathione levels were still suppressed by 62% at 24 h compared with untreated controls (19.7 +/- 2.6 micromol/g). Glutathione disulfide (GSSG) concentrations were elevated by 455% compared with controls (74 +/- 3 nmol/g liver). Treatment with GSH at 1.5 h after AAP treatment attenuated liver necrosis and plasma ALT activities by 62 to 66% at 24 h. All animals survived up to 7 days. The hepatic GSH content recovered to control values; however, the GSSG levels were still elevated at 48 h (252 +/- 26 nmol/g). Expression of proliferating cell nuclear antigen (PCNA) and cell cycle proteins cyclin D1 and p21 were not detectable in controls or after AAP alone. Treatment with GSH after AAP induced expression of cyclin D1, p21, and PCNA (12-48 h). Thus, GSH treatment after AAP provided long-term hepatoprotection and promotes progression of cell cycle activation in hepatocytes.
Bajt
Mary Lynn
ML
Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, USA. mlb3@email.arizona.edu
Knight
Tamara R
TR
Farhood
Anwar
A
Jaeschke
Hartmut
H
D000082:Acetaminophen / Q000633:toxicity*; D000818:Animals; D004195:Disease Models, Animal; D005978:Glutathione / Q000627:therapeutic use*; D019803:Glutathione Disulfide / Q000627:therapeutic use; D007150:Immunohistochemistry; D008115:Liver Regeneration / Q000187:drug effects*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D030421:Peroxynitrous Acid / Q000378:metabolism*; D012128:Respiratory Distress Syndrome / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control*; D015996:Survival Rate
D030421:Peroxynitrous Acid; D000082:Acetaminophen; D005978:Glutathione; D019803:Glutathione Disulfide